Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure.

No abstract is available for this paper.

• Publication year

  1975

• Venue

  Cancer Research

• Publication date

  1975-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1149045
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transplantation of adenocarcinomas of the colon in mice.

  1975cited by this paper
• Transplantation of adenocarcinomas of the colon in mice.

  1975cited by this paper
• Transplantation of chemically induced adenocarcinomas of the colon in an inbred strain of rats

  1974cited by this paper
• The Influence of Fibrin Formation on the Transplantability of Murine Tumour Cells: Implications for the Mechanism of the Révész Effect

  1974cited by this paper
• Cancer statistics 1973

  1973cited by this paper
• Induction of adenocarcinomas of the colon in mice by weekly injections of 1,2-dimethylhydrazine.

  1973cited by this paper
• Carcinoma of the colon and rectum of rats by rectal infusion of N-methyl-N'-nitro-N-nitrosoguanidine.

  1971cited by this paper
• Colon carcinogens: Their metabolism and mode of action

  1971cited by this paper
• The induction of intestinal neoplasms in rats with the glycoside cycasin and its aglycone

  1965cited by this paper
• Effect of lethally damaged tumor cells upon the development of admixed viable cells.

  1958cited by this paper

• Development and characterization of immortalized mouse intestinal epithelial cell lines.

  2026cites this paper
• Multiple organs exhibit exacerbated cachexia in male mice with colon cancer than females.

  2025cites this paper
• Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic

  2025cites this paper
• Virulence factor discovery identifies associations between the Fic gene family and Fap2+ fusobacteria in colorectal cancer microbiomes

  2025cites this paper
• Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy

  2025cites this paper
• DETECTION OF HUMAN PD-1 ON T-CELLS USING A FUSION PROTEIN CONSISTING OF AN ANTI-PD-1 SINGLE CHAIN VARIABLE FRAGMENT LINKED TO SUPERFOLDER GFP.

  2025cites this paper
• Noncanonical Hedgehog signaling through Smoothened controls cytotoxic T cell migration in the tumor microenvironment

  2025cites this paper
• A neoantigen-microbead platform for personalized T cell cancer vaccination

  2025cites this paper
• Inhibition of KDEL receptors remodels the tumor microenvironment for robust T cell independent tumor regression

  2025cites this paper
• Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signaling

  2025cites this paper
• A targeted MAVS fusion protein for controlled innate immune activation and antitumor therapy

  2025cites this paper
• Anticancer signal transduction pathways of selenium nanoparticles in mouse colorectal cancer model.

  2025cites this paper
• Fluorinated Ribonucleocarbohydrate Nanoparticles Allow Ultraefficient mRNA Delivery and Protein Expression in Tumor-Associated Myeloid Cells

  2025cites this paper
• Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy

  2025cites this paper
• A preclinical model for the identification of therapeutically active transgenes in local cancer immunotherapy

  2025cites this paper
• IL-2/IL-15 signaling induces NK cell production of FLT3LG augmenting anti-PD-1 immunotherapy.

  2025cites this paper
• Nintedanib enhances tumor cell radiosensitivity by promoting ferroptosis and modulating the ATF4/SLC7A11/GSH axis

  2025cites this paper
• A lentiviral vector targeting a KRAS neoepitope for cancer immunotherapy

  2025cites this paper
• Cell-type-specific requirement for TYK2 in murine immune cells under steady state and challenged conditions

  2025cites this paper
• Anterior cingulate cortex mediates the comorbidity between colorectal cancer and depression-like behaviors

  2025cites this paper
• Escitalopram facilitates tumor growth and metastasis in rodents: Is it safe?

  2025cites this paper
• Mouse colorectal cancer organoids: Lessons from syngeneic and orthotopic transplantation systems.

  2025cites this paper
• CD8 T Cell Hyperfunction and Reduced Tumour Control in Murine Models of Advanced Liver Disease

  2025cites this paper
• Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4+ T cell response

  2024cites this paper
• Assessment of molecular modulation by multifrequency electromagnetic pulses to preferably eradicate tumorigenic cells

  2024cites this paper
• Perioperative hypothermia and stress jeopardize antimetastatic immunity and TLR-9 immune activation: potential mediating mechanisms (experimental studies)

  2024cites this paper
• Nucleocytoplasmic transport senses mechanical forces independently of cell density in cell monolayers

  2024cites this paper
• MiR-155-targeted IcosL controls tumor rejection

  2024cites this paper
• A Diet Lacking Selenium, but Not Zinc, Copper or Manganese, Induces Anticancer Activity in Mice with Metastatic Cancers

  2024cites this paper
• IL-1R signaling drives enteric glia-macrophage interactions in colorectal cancer

  2024cites this paper
• Preventive intervention with Agaricus blazei murill polysaccharide exerts anti-tumor immune effect on intraperitoneal metastasis colorectal cancer.

  2024cites this paper
• The nuclear factor ID3 endows macrophages with a potent anti-tumour activity

  2024cites this paper
• Crucial role of dendritic cells in the generation of anti-tumor T-cell responses and immunogenic tumor microenvironment to suppress tumor development

  2024cites this paper
• A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy.

  2024cites this paper
• Nucleocytoplasmic transport senses mechanics independently of cell density in cell monolayers

  2024cites this paper
• A novel small molecule Enpp1 inhibitor improves tumor control following radiation therapy by targeting stromal Enpp1 expression

  2024cites this paper
• Enhanced systemic antitumor efficacy of PD‐1/PD‐L1 blockade with immunological response induced by photodynamic therapy

  2024cites this paper
• Cholesterol synthesis is essential for the growth of liver metastasis‐prone colorectal cancer cells

  2024cites this paper
• PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways

  2024cites this paper
• Exploring Heterogeneity: A Dive into Pre-Clinical Models of Cancer Cachexia.

  2024cites this paper
• Sensitization with an allogeneic MHC class I molecule induces anti-tumor immunity in the absence of PD-1 in mice

  2023cites this paper
• IL-1R signaling drives enteric glia-macrophage interactions in colorectal cancer

  2023cites this paper
• Advancing translational research for colorectal immuno-oncology

  2023cites this paper
• Females Display Relatively Preserved Muscle Quality Compared to Males During the Onset and Early Stages of C26-induced Cancer-Cachexia.

  2023cites this paper
• Cancer immunotherapy with enveloped self-amplifying mRNA CARG-2020 that modulates IL-12, IL-17 and PD-L1 pathways to prevent tumor recurrence

  2023cites this paper
• Molecular approaches to identify cancer T cell antigens and improve immunogenicity

  2023cites this paper
• Variable body and tissue weight reporting in preclinical cachexia literature may alter study outcomes and interpretation

  2023cites this paper
• Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity

  2023cites this paper
• CD8 T cell hyperfunction and reduced tumour control in models of advanced liver fibrosis

  2023cites this paper
• TREM2 mediates MHCII-associated CD4+ T cell response against gliomas

  2023cites this paper
• Granulocyte colony stimulating factor is a novel mediator of T cell suppression and an immunotherapeutic target for women with colon cancer.

  2023cites this paper
• Effects of regorafenib on the mononuclear/phagocyte system and how these contribute to the inhibition of colorectal tumors in mice

  2023cites this paper
• Late-stage MC38 tumours recapitulate features of human colorectal cancer – implications for appropriate timepoint selection in preclinical studies

  2023cites this paper
• Combined therapeutic effect of YHO-1701 with PD-1 blockade is dependent on natural killer cell activity in syngeneic mouse models

  2023cites this paper
• Netrin-1 promotes the immunosuppressive activity of MDSCs in colorectal cancer.

  2023cites this paper
• OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum

  2023cites this paper
• Targeted bacteria-mediated therapy of mouse colorectal cancer using baicalin, a natural glucuronide compound, and E. coli overexpressing β-glucuronidase.

  2023cites this paper
• Artificial Diets with Selective Restriction of Amino Acids and Very Low Levels of Lipids Induce Anticancer Activity in Mice with Metastatic Triple-Negative Breast Cancer

  2023cites this paper
• MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression

  2023cites this paper
• Tumor loss-of-function mutations in STK11/LKB1 induce cachexia

  2023cites this paper
• TREM2 mediates MHCII-associated CD4+ T cell response against gliomas.

  2023cites this paper
• Decoupling FcRn and Tumor Contributions to Elevated Immune Checkpoint Inhibitor Clearance in Cancer Cachexia.

  2023cites this paper
• CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses

  2023cites this paper
• GZMKhigh CD8+ T effector memory cells are associated with CD15high neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome

  2022cites this paper
• Isolation of endogenous cytosolic DNA from cultured cells

  2022cites this paper
• The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis

  2022cites this paper
• PD-L1 Aptamer-Functionalized Metal-Organic Framework Nanoparticles for Robust Photo-Immunotherapy Against Cancer with Enhanced Safety.

  2022cites this paper
• Cancer-derived cholesterol sulfate is a key mediator to prevent tumor infiltration by effector T cells

  2022cites this paper
• shRNAs targeting mouse Adam10 diminish cell response to proinflammatory stimuli independently of Adam10 silencing

  2022cites this paper
• Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer

  2022cites this paper
• HDACi promotes inflammatory remodeling of the tumor microenvironment to enhance epitope spreading and antitumor immunity

  2022cites this paper
• Nuanced role for dendritic cell intrinsic IRE1 RNase in the regulation of antitumor adaptive immunity

  2022cites this paper
• Evolution of preclinical characterization and insights into clinical pharmacology of checkpoint inhibitors approved for cancer immunotherapy

  2022cites this paper
• Trends in Subcutaneous Tumour Height and Impact on Measurement Accuracy

  2022cites this paper
• Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer Immunotherapy

  2022cites this paper
• Dual-acting antitumor agents targeting the A2A adenosine receptor and histone deacetylases: Design and synthesis of 4-(furan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine derivatives.

  2022cites this paper
• The myokine Fibcd1 is an endogenous determinant of myofiber size and mitigates cancer-induced myofiber atrophy

  2022cites this paper
• Oral Installation of Recombinant Methioninase-producing Escherichia coli into the Microbiome Inhibits Colon-cancer Growth in a Syngeneic Mouse Model

  2022cites this paper
• Unique roles of co-receptor-bound LCK in helper and cytotoxic T cells

  2022cites this paper
• Apelin-driven endothelial cell migration sustains intestinal progenitor cells and tumor growth

  2022cites this paper
• T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses In Vivo

  2021influential citation
• Adjuvant properties of IFN-γ and GM-CSF in the scFv6.C4 DNA vaccine against CEA-expressing tumors

  2021cites this paper
• Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop.

  2021cites this paper
• Deletion of mTOR in liver epithelial cells enhances hepatic metastasis of colon cancer

  2021cites this paper
• GZMKhigh CD8+ T effector memory cells are associated with CD15high neutrophil abundance in early-stage colorectal tumors and predict poor clinical outcome

  2021cites this paper
• OX40 agonism enhances efficacy of PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum

  2021cites this paper
• GPR15 in colon cancer development and anti-tumor immune responses

  2021cites this paper
• Structural basis for IL-12 and IL-23 shared receptor usage reveals a gateway for shaping actions on T versus NK cells

  2021cites this paper
• Non-targeting control for MISSION shRNA library silences SNRPD3 leading to cell death or permanent growth arrest

  2021cites this paper
• Development of Immunotherapy Combination Strategies in Cancer.

  2021cites this paper
• The interplay of immunology and cachexia in infection and cancer

  2021cites this paper
• The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota

  2021cites this paper
• Targeting the Atf7ip–Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity

  2021cites this paper
• Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.

  2021cites this paper
• Development of an Orthotopic Murine Model of Rectal Cancer in Conjunction With Targeted Short-Course Radiation Therapy

  2021cites this paper
• Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth

  2021cites this paper
• Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors

  2021cites this paper
• The solute carrier MFSD1 decreases β1 integrin’s activation status and thus tumor metastasis

  2021cites this paper
• Phytic acid potentiates oxaliplatin effects in colorectal cancer induced by 1,2-DMH: the role of miR-224 and miR-200a

  2021cites this paper
• Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells.

  2021cites this paper